Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05215158Completed
Randomised trial of dexmedetomidine in strabismus (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Duration of analgesia at 12 hours. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05215158.